HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wu, J. Articles by Spies, T. Search for Related Content PubMed PubMed Citation Articles by Wu, J. Articles by Spies, T.

Intracellular Retention of the MHC Class I-Related Chain B Ligand of NKG2D by the Human Cytomegalovirus UL16 Glycoprotein¹

Jennifer Wu^*, N. Jan Chalupny, Thomas J. Manley^*, Stanley R. Riddell^*, David Cosman and Thomas Spies^2,*

^* Fred Hutchinson Cancer Research Center, Seattle, WA 98109; and Amgen, Seattle, WA 98101

Infection by human CMV induces expression of the cellular MHC class I-related chain A (MICA) and chain B (MICB) surface proteins, which function as ligands for the activating NKG2D receptor. Engagement of NKG2D triggers NK cells and costimulates Ag-specific effector CD8 T cells. The potency of MHC class I-related chain-NKG2D in stimulating these anti-viral immune responses may be countered by a CMV-encoded transmembrane glycoprotein, UL16, which specifically binds MICB as well as two of the UL16-binding proteins that are ligands of NKG2D. However, the function and significance of these interactions are undefined. Using a stably transfected B cell line, we show that expression of UL16 results in loss of surface MICB. This effect is caused by the failure of newly synthesized MICB to mature and transit the secretory pathway due to physical association with UL16. The intracellular retention of these protein complexes is mediated by a tyrosine-based motif in the cytoplasmic tail sequence of UL16, which determines localization to or retrieval from the trans-Golgi network. Deletion of this motif restores surface expression of MICB, whereas UL16 may be redirected to endosomal compartments. Predictably, the retention of MICB abrogates the stimulatory function of NKG2D. These results suggest a potential mechanism of viral immune evasion. However, this activity remains to be confirmed with CMV-infected fibroblasts or endothelial cells, in particular because MICB is normally coexpressed with MICA, which is not retained by UL16.

This article has been cited by other articles:

				O. Ashiru, N. J. Bennett, L. H. Boyle, M. Thomas, J. Trowsdale, and M. R. Wills NKG2D Ligand MICA Is Retained in the cis-Golgi Apparatus by Human Cytomegalovirus Protein UL142 J. Virol., December 1, 2009; 83(23): 12345 - 12354. [Abstract] [Full Text] [PDF]

				J. Arapovic, T. Lenac, R. Antulov, B. Polic, Z. Ruzsics, L. N. Carayannopoulos, U. H. Koszinowski, A. Krmpotic, and S. Jonjic Differential Susceptibility of RAE-1 Isoforms to Mouse Cytomegalovirus J. Virol., August 15, 2009; 83(16): 8198 - 8207. [Abstract] [Full Text] [PDF]

				M. Jarahian, C. Watzl, P. Fournier, A. Arnold, D. Djandji, S. Zahedi, A. Cerwenka, A. Paschen, V. Schirrmacher, and F. Momburg Activation of Natural Killer Cells by Newcastle Disease Virus Hemagglutinin-Neuraminidase J. Virol., August 15, 2009; 83(16): 8108 - 8121. [Abstract] [Full Text] [PDF]

				S. Aguera-Gonzalez, P. Boutet, H. T. Reyburn, and M. Vales-Gomez Brief Residence at the Plasma Membrane of the MHC Class I-Related Chain B Is Due to Clathrin-Mediated Cholesterol-Dependent Endocytosis and Shedding J. Immunol., April 15, 2009; 182(8): 4800 - 4808. [Abstract] [Full Text] [PDF]

				J. D. Wu, C. L. Atteridge, X. Wang, T. Seya, and S. R. Plymate Obstructing Shedding of the Immunostimulatory MHC Class I Chain-Related Gene B Prevents Tumor Formation Clin. Cancer Res., January 15, 2009; 15(2): 632 - 640. [Abstract] [Full Text] [PDF]

				M. Draghi, A. Pashine, B. Sanjanwala, K. Gendzekhadze, C. Cantoni, D. Cosman, A. Moretta, N. M. Valiante, and P. Parham NKp46 and NKG2D Recognition of Infected Dendritic Cells Is Necessary for NK Cell Activation in the Human Response to Influenza Infection J. Immunol., March 1, 2007; 178(5): 2688 - 2698. [Abstract] [Full Text] [PDF]

				A. Lopez-Soto, A. Quinones-Lombrana, R. Lopez-Arbesu, C. Lopez-Larrea, and S. Gonzalez Transcriptional Regulation of ULBP1, a Human Ligand of the NKG2D Receptor J. Biol. Chem., October 13, 2006; 281(41): 30419 - 30430. [Abstract] [Full Text] [PDF]

				K. Tosh, M. Ravikumar, J. T. Bell, S. Meisner, A. V.S. Hill, and R. Pitchappan Variation in MICA and MICB genes and enhanced susceptibility to paucibacillary leprosy in South India Hum. Mol. Genet., October 1, 2006; 15(19): 2880 - 2887. [Abstract] [Full Text] [PDF]

				J. Spreu, T. Stehle, and A. Steinle Human Cytomegalovirus-Encoded UL16 Discriminates MIC Molecules by Their {alpha}2 Domains. J. Immunol., September 1, 2006; 177(5): 3143 - 3149. [Abstract] [Full Text] [PDF]

				A. Iannello, O. Debbeche, E. Martin, L. H. Attalah, S. Samarani, and A. Ahmad Viral strategies for evading antiviral cellular immune responses of the host J. Leukoc. Biol., January 1, 2006; 79(1): 16 - 35. [Abstract] [Full Text] [PDF]

				A. K. Kriegeskorte, F. E. Gebhardt, S. Porcellini, M. Schiemann, C. Stemberger, T. J. Franz, K. M. Huster, L. N. Carayannopoulos, W. M. Yokoyama, M. Colonna, et al. NKG2D-independent suppression of T cell proliferation by H60 and MICA PNAS, August 16, 2005; 102(33): 11805 - 11810. [Abstract] [Full Text] [PDF]

				D. Garrity, M. E. Call, J. Feng, and K. W. Wucherpfennig The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure PNAS, May 24, 2005; 102(21): 7641 - 7646. [Abstract] [Full Text] [PDF]

				P. Nowbakht, M.-C. S. Ionescu, A. Rohner, C. P. Kalberer, E. Rossy, L. Mori, D. Cosman, G. De Libero, and A. Wodnar-Filipowicz Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias Blood, May 1, 2005; 105(9): 3615 - 3622. [Abstract] [Full Text] [PDF]

				M. Hasan, A. Krmpotic, Z. Ruzsics, I. Bubic, T. Lenac, A. Halenius, A. Loewendorf, M. Messerle, H. Hengel, S. Jonjic, et al. Selective Down-Regulation of the NKG2D Ligand H60 by Mouse Cytomegalovirus m155 Glycoprotein J. Virol., March 1, 2005; 79(5): 2920 - 2930. [Abstract] [Full Text] [PDF]

				Y. Zou, W. Bresnahan, R. T. Taylor, and P. Stastny Effect of Human Cytomegalovirus on Expression of MHC Class I-Related Chains A J. Immunol., March 1, 2005; 174(5): 3098 - 3104. [Abstract] [Full Text] [PDF]

				A. Krmpotic, M. Hasan, A. Loewendorf, T. Saulig, A. Halenius, T. Lenac, B. Polic, I. Bubic, A. Kriegeskorte, E. Pernjak-Pugel, et al. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145 J. Exp. Med., January 18, 2005; 201(2): 211 - 220. [Abstract] [Full Text] [PDF]

				M. J. Smyth, J. Swann, J. M. Kelly, E. Cretney, W. M. Yokoyama, A. Diefenbach, T. J. Sayers, and Y. Hayakawa NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of Cancer J. Exp. Med., November 15, 2004; 200(10): 1325 - 1335. [Abstract] [Full Text] [PDF]

				M. B. Lodoen, G. Abenes, S. Umamoto, J. P. Houchins, F. Liu, and L. L. Lanier The Cytomegalovirus m155 Gene Product Subverts Natural Killer Cell Antiviral Protection by Disruption of H60-NKG2D Interactions J. Exp. Med., October 18, 2004; 200(8): 1075 - 1081. [Abstract] [Full Text] [PDF]

				D. B. Rosen, M. Araki, J. A. Hamerman, T. Chen, T. Yamamura, and L. L. Lanier A Structural Basis for the Association of DAP12 with Mouse, but Not Human, NKG2D J. Immunol., August 15, 2004; 173(4): 2470 - 2478. [Abstract] [Full Text] [PDF]